# Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis

> **NCT04480359** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 80 (estimated)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Bawei Shenqi Pill
- **DRUG:** Bawei Shenqi Pill placebo
- **DRUG:** Meloxicam

## Key facts

- **NCT ID:** NCT04480359
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04480359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04480359, "Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04480359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*